Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Clavis initiates recruitment in phase II clinical study of Elacyt in hematological cancers

April 8, 2008

In vivo efficacy of BMS-641988, a novel androgen receptor antagonist

April 8, 2008

Genetic studies find link to lung cancer

April 8, 2008

EpiCept reports positive clinical data from phase I EPC-2407 trial

April 7, 2008

Alfacell reports evaluable events from phase IIIb clinical trial of Onconase

April 7, 2008

EntreMed initiates phase I clinical trial of MKC-1 in metastatic solid tumors

April 7, 2008

Efficacy of radiotherapy enhanced by SPI-1620

April 7, 2008

AZD-1480, a novel JAK2 inhibitor profiled at AstraZeneca

April 7, 2008

EMEA accepts for review Cell Therapeutics' MAA for Xyotax in NSCLC

April 4, 2008

Carfilzomib receives FDA orphan drug designation in multiple myeloma

April 4, 2008

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...